1. Home
  2. INUV vs LPCN Comparison

INUV vs LPCN Comparison

Compare INUV & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INUV
  • LPCN
  • Stock Information
  • Founded
  • INUV N/A
  • LPCN N/A
  • Country
  • INUV United States
  • LPCN United States
  • Employees
  • INUV N/A
  • LPCN N/A
  • Industry
  • INUV Advertising
  • LPCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • INUV Consumer Discretionary
  • LPCN Health Care
  • Exchange
  • INUV Nasdaq
  • LPCN Nasdaq
  • Market Cap
  • INUV 37.4M
  • LPCN 36.8M
  • IPO Year
  • INUV N/A
  • LPCN N/A
  • Fundamental
  • Price
  • INUV $0.34
  • LPCN $5.65
  • Analyst Decision
  • INUV Strong Buy
  • LPCN Buy
  • Analyst Count
  • INUV 1
  • LPCN 1
  • Target Price
  • INUV $1.00
  • LPCN $33.00
  • AVG Volume (30 Days)
  • INUV 472.5K
  • LPCN 43.3K
  • Earning Date
  • INUV 08-08-2024
  • LPCN 08-08-2024
  • Dividend Yield
  • INUV N/A
  • LPCN N/A
  • EPS Growth
  • INUV N/A
  • LPCN N/A
  • EPS
  • INUV N/A
  • LPCN N/A
  • Revenue
  • INUV $79,087,865.00
  • LPCN $4,711,366.00
  • Revenue This Year
  • INUV $30.06
  • LPCN N/A
  • Revenue Next Year
  • INUV $18.30
  • LPCN $81.58
  • P/E Ratio
  • INUV N/A
  • LPCN N/A
  • Revenue Growth
  • INUV 14.88
  • LPCN 748.91
  • 52 Week Low
  • INUV $0.12
  • LPCN $2.31
  • 52 Week High
  • INUV $0.57
  • LPCN $11.79
  • Technical
  • Relative Strength Index (RSI)
  • INUV 65.69
  • LPCN 35.66
  • Support Level
  • INUV $0.25
  • LPCN $7.50
  • Resistance Level
  • INUV $0.37
  • LPCN $7.90
  • Average True Range (ATR)
  • INUV 0.02
  • LPCN 0.61
  • MACD
  • INUV 0.01
  • LPCN -0.30
  • Stochastic Oscillator
  • INUV 78.17
  • LPCN 7.28

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications, and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: